PI3K-IN-55
PI3K-IN-55 (Compound 6a) is a potent inhibitor for PI3K. PI3K-IN-55 affects PI3K/Akt/p53 signaling pathway, inhibits the proliferation of cancer cells A549, Hela, HepG2, MCF-7 and HT-29, with IC50s of 1.03-6.78 μM. PI3K-IN-55 induces apoptosis in cell MCF-7[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3k-in-55.html
Smiles
O=C(/C(C(/C=C/C1=CC=C(OCCO[N+]([O-])=O)C(OC)=C1)=O)=C/C2=CC=CS2)/C=C/C3=CC(OC)=C(OCCO[N+]([O-])=O)C=C3
Molecular Formula
C30H28N2O12S
Molecular Weight
640.61
References & Citations
[1]Zhou H, et al., In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway. Mol Divers. 2024 Jul 1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Scn1a Mouse Monoclonal Antibody [Clone ID: K74/71]](https://cdn.genprice.uk/products/937/68dd1898061270361e8fb373/imageurl/75-023.webp)
BNC942233-100 1x 100 µL
Creatine Phosphokinase-BB (CK-BB) (CPTC-CKB-2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942424-500 1x 500 µL
BOB.1 (B-Cell Marker) (BOB1/2424), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 